Assignee
BIOSPLICE THERAPEUTICS INC
US·18 granted patents·13 pending applications·34 citations·filing 2019–2025
Top patents by PatentIndex Score
31 records- 0197US11697649B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofBIOSPLICE THERAPEUTICS INC·Filed 2021·Granted Jul 11, 2023·3 cites·31 claims
- 0297US11446288B2Single-dose, ready-to-use injectable formulationsBIOSPLICE THERAPEUTICS INC·Filed 2020·Granted Sep 20, 2022·6 cites·41 claims
- 0396US11066388B2Indazole-3-carboxamides and their use as WNT/B-catenin signaling pathway inhibitorsBIOSPLICE THERAPEUTICS INC·Filed 2019·Granted Jul 20, 2021·8 cites·28 claims
- 0495US11560378B2Treatment of osteoarthritisBIOSPLICE THERAPEUTICS INC·Filed 2020·Granted Jan 24, 2023·3 cites·8 claims
- 0595US11548872B2Isoquinolin-3-yl carboxamides and preparation and use thereofBIOSPLICE THERAPEUTICS INC·Filed 2021·Granted Jan 10, 2023·2 cites·37 claims
- 0692US11667632B22-(1H-indazol-3-yl)-3H-imidazo[4,5-C]pyridines and their anti-inflammatory uses thereofBIOSPLICE THERAPEUTICS INC·Filed 2020·Granted Jun 6, 2023·2 cites·8 claims
- 0791US11780823B2Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitorsBIOSPLICE THERAPEUTICS INC·Filed 2021·Granted Oct 10, 2023·1 cites·2 claims
- 0890US11673881B2Isoquinolin-3-yl carboxamides and preparation and use thereofBIOSPLICE THERAPEUTICS INC·Filed 2021·Granted Jun 13, 2023·1 cites·42 claims
- 0990US11174244B2Isoquinolin-3-yl carboxamides and preparation and use thereofBIOSPLICE THERAPEUTICS INC·Filed 2019·Granted Nov 16, 2021·3 cites·50 claims
- 1089US11673885B2γ-diketones as Wnt/β-catenin signaling pathway activatorsBIOSPLICE THERAPEUTICS INC·Filed 2021·Granted Jun 13, 2023·1 cites·17 claims
- 1188US11684615B2Methods of using indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitorsBIOSPLICE THERAPEUTICS INC·Filed 2020·Granted Jun 27, 2023·2 cites·31 claims
- 1286US2024116927A1Indazole inhibitors of the wnt signal pathway and therapeutic uses thereofBIOSPLICE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1385US12281097B2Isoquinolin-3-yl carboxamides and preparation and use thereofBIOSPLICE THERAPEUTICS INC·Filed 2022·Granted Apr 22, 2025·0 cites·21 claims
- 1485US12012401B2Process for preparing N-(5-(3-(7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamideBIOSPLICE THERAPEUTICS INC·Filed 2021·Granted Jun 18, 2024·1 cites·18 claims
- 1585US11077046B2Gamma-diketones for treatment and prevention of aging skin and wrinklesBIOSPLICE THERAPEUTICS INC·Filed 2019·Granted Aug 3, 2021·1 cites·11 claims
- 1684US2025109131A1Process for preparing n-(5-(3-(7-(3-fluorophenyl)-3h-imidazo[4,5-c]pyridin-2-yl)-1h-indazol-5-yl)pyridin-3-yl)-3-methylbutanamideBIOSPLICE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1781US2026022108A1Isoquinolin-3-yl carboxamides and preparation and use thereofBIOSPLICE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1879US11819499B2Single-dose, ready-to-use injectable formulationsBIOSPLICE THERAPEUTICS INC·Filed 2022·Granted Nov 21, 2023·0 cites·45 claims
- 1976US11839679B2Gamma-diketones for treatment and prevention of aging skin and wrinklesBIOSPLICE THERAPEUTICS INC·Filed 2021·Granted Dec 12, 2023·0 cites·16 claims
- 2076US2021353604A1ß- AND y -DIKETONES AND y -HYDROXYKETONES AS WNT/ ß -CATENIN SIGNALING PATHWAY ACTIVATORSBIOSPLICE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2175US2025129104A17h-pyrrolo[2,3-d]pyrimidines and preparation and uses thereofBIOSPLICE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2274US2025171466A1Pyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereofBIOSPLICE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2367US12134625B2Pyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereofBIOSPLICE THERAPEUTICS INC·Filed 2022·Granted Nov 5, 2024·0 cites·12 claims
- 2465US2025206746A14-alkoxypyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereofBIOSPLICE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2565US2023167133A17h-pyrrolo[2,3-d]pyrimidines and preparation and uses thereofBIOSPLICE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2664US11713320B25-heteroaryl substituted indazole-3-carboxamides and preparation and use thereofBIOSPLICE THERAPEUTICS INC·Filed 2020·Granted Aug 1, 2023·0 cites·24 claims
- 2761US2023192686A11h-pyrrolo[2,3-b]pyridines and preparation and uses thereofBIOSPLICE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2860US2024199649A14-aminopyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereofBIOSPLICE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2959US2024002391A14-alkoxypyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereofBIOSPLICE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3051US2025340575A14-aminopyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereofBIOSPLICE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3142US2022062240A1Methods of treating cancer using a clk inhibitorBIOSPLICE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BIOSPLICE THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →